Main Timeline Video Share
May the Holiday Warm Hearts: Idram and IDBank Support the Children of Heroes Beneficiaries of the "By Your Side" program at IDBank AraratBank Named Large CSR Company of the Year Idram Joins the Fight Against Food Insecurity Ucom’s Renovated Sales and Service Center in Yerevan Mall Reopens 1% idcoin instead of New Year’s suffering: practical tips Idram Junior Donated Books to Schools Big Christmas Market with Idram, IDBank and idplus Ucom Supports Wildlife Monitoring in Ararat Region IDBank, Idram, and idplus at the Big Christmas Market Converse Bank Deputy CEO and CFO, Grant Akopian, Elected to BACEE Board Ucom and SunChild NGO Install a Solar Plant in Alaverdi Kindergarten
AraratBank Employees Communicated with the Power of the Intercessory Gospel of ShurishkanMyAmeria Star - Ameriabank presents a bank card and app for kids and teens One more free access to business lounges: IDBank How to protect your bank accounts and E-WalletAraratBank: Supporting SMEs for About 20 YearsIDBank – Supporting SMEs "Face to Face" with "The Power of One Dram"With Ucom’s Support “DemArDem: Dialogue of Generations” Regional Forum Concludes in Tashir Idram is now available in Yerevan CityNew Offer for Residents of 28 Cities with 5G Network Joining Ucom Ucom Joins the Regional Forum “DemArDem: Dialogue of Generations” AraratBank: The Only Victory is the Smile of a Recovered Child Financially Literate with Idram Junior IDBank new branch is in the City of ArtashatNew campaign from IDBank on the occasion of Client’s Day Ucom Celebrates International Client's Day, Strengthening Ties with Subscribers Ucom’s Fixed Network Now Available in Yeghvard 4,664,972 AMD to QaylTech. The beneficiary of The Power of One Dram for March is the Heroes Rehabilitation City Ucom Fellowship Incubation Program Concludes with Inspiring Closing Ceremony and Awards Event Preferential registration for the FINTECH360conference is available until March 15
Life

1 in 4 people face side effects after getting COVID-19 vaccine

One in four people experiences side effects after being vaccinated against coronavirus. These are mostly minor side effects like pain at the injection site or headache, Lancet Infectious Diseases reported.

Analysis of data from the ZOE COVID Symptom Study, conducted by researchers at King's College London, found that side effects in the general population after vaccination with Pfizer and AstraZeneca were much lower than those reported in the trials.

The study also reported a significant reduction in infection rates from 12 to 21 days after the first dose of Pfizer (58% reduction) and AstraZeneca (39% reduction) compared to controls. The reduction in infection at least 21 days after the first dose is 69% for Pfizer and 60% for AstraZeneca.

Research has shown that:

  • 25.4% of vaccinated people reported one or more systemic side effects, while 66.2% reported one or more local side effects.
  • 13.5% of participants reported side effects after the first dose of Pfizer, 22.0% after the second dose of Pfizer, and 33.7% after the first dose of AstraZeneca.
  • The most common systemic side effect was a headache. 7.8% of people reported headaches after the first dose of Pfizer and 13.2% after the second dose of Pfizer. 22.8% of people who received the first dose of the AstraZeneca vaccine reported headaches.
  • The second most common systemic side effect was fatigue. 8.4% and 14.4% of participants reported fatigue after the first and second doses of the Pfizer vaccine, and 21.1% reported fatigue after the first dose of the AstraZeneca vaccine.
  • The most common localized side effect was soreness: 57.2% and 50.9% after the first and second doses of Pfizer vaccine and 49.3% after the first dose of AstraZeneca vaccine.

Side effects were more common in people under the age of 55 and in women.